Aspire Capital Partners LLC
Aspire Capital Partners LLC is a Chicago-based investment fund with a focus on making direct investments in publicly traded companies in a
Business Model:
Revenue: $8.5M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Aspire Capital Partners LLC Information
Geographic Data
Address: 155 N Wacker Dr
City: Chicago
State: IL
Zip: 60606
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
6,896,199Website Global Rank
684Website Monthly Traffic
Twitter Followers
Description
Aspire Capital Fund LLC is a Chicago-based investment fund with a focus on making direct investments in publicly traded companies in a broad range of industries and investment structures. Aspire Capital Fund LLC is managed by Aspire Capital Partners LLC. They offer innovative investment structures designed for publicly traded companies whose prospects are bright, but who need additional capital to fuel their growth. Aspire Capital provides these companies with an easy and fair way to sell equity as the company achieves its business objectives.
Contact Phone:
+13126580400
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2014 | Sophiris Bio | Post-IPO Equity | 2M |
| 10/2011 | Kips Bay Medical | Post-IPO Equity | - |
| 8/2012 | MediciNova | Post-IPO Equity | 20M |
| 8/2019 | Titan Medical | Post-IPO Equity | 0 |
| 12/2015 | Ritter Pharmaceuticals | Post-IPO Equity | 0 |
| 8/2016 | Viking Therapeutics | Post-IPO Equity | 0 |
| 6/2020 | Mereo Biopharma | Post-IPO Equity | 0 |
| 9/2019 | Novan | Post-IPO Equity | 0 |
| 4/2014 | Mobiquity Technologies | Post-IPO Equity | 0 |
| 11/2011 | Athersys | Post-IPO Equity | 20M |
| 3/2021 | Satsuma Pharmaceuticals | Post-IPO Equity | 0 |
| 12/2020 | Solid Biosciences | Post-IPO Equity | 0 |
| 5/2015 | Atossa Genetics | Post-IPO Equity | 0 |
| 3/2021 | Satsuma Pharmaceuticals | Post-IPO Equity | 0 |
| 12/2020 | Solid Biosciences | Post-IPO Equity | 0 |
| 6/2020 | Mereo Biopharma | Post-IPO Equity | 0 |
| 9/2019 | Novan | Post-IPO Equity | 0 |
| 8/2019 | Titan Medical | Post-IPO Equity | 0 |
| 8/2016 | Viking Therapeutics | Post-IPO Equity | 0 |
| 12/2015 | Ritter Pharmaceuticals | Post-IPO Equity | 0 |
| 5/2015 | Atossa Genetics | Post-IPO Equity | 0 |
| 5/2014 | Sophiris Bio | Post-IPO Equity | 0 |
| 4/2014 | Mobiquity Technologies | Post-IPO Equity | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
